Table 1. Basal biological and clinical characteristics of HIV-infected patients.
| Variable | n = 149 |
| Age, yrs [mean (SD)] | 48.57 (10.15) |
| Sex [male, (%)] | 117 (78.5) |
| Transmission group, (%) | |
| Homosexual/bisexual | 42.6 |
| Heterosexual | 37.2 |
| Intravenous drug users | 25 |
| Others/unknown | 3.4 |
| Type 2 diabetes, n (%) | 8 (5.4) |
| Hypertension, n (%) | 27 (18.2) |
| Dyslipidemia, n (%) | 47 (31.5) |
| Current Smoker, n (%) | 81 (55,5) |
| ART, years [mean (SD)] | 4.1 [2.0, 9.0] |
| Alcohol consumption, n (%) | 74 (51.0) |
| Drug user, n (%) | 19 (13.4) |
| Coronary heart disease, n (%) | 7 (4.8) |
| Stroke, n (%) | 2 (1.4) |
| AIDS (%) | 31 (23.0) |
| On ART, n (%) | |
| Protease inhibitor, n (%) | 40 (26.8) |
| NNRTI, n (%) | 47 (32.0) |
| Integrase inhibitor, n (%) | 75 (51.0) |
| Other ART combination (%) | 23 (15.6) |
| Carotid plaques, n (%) | 23 (16.7) |
| Carotid SCA, n (%) | 61 (44.2) |
| CD4 nadir | 256.00 [119.50, 422.50] |
| BMI | 26.47 [23.59, 28.84] |
| CD4+ T-cell count, cells/mL | 736.00 [471.00, 966.50] |
| CD4/CD8 ratio | 0.83 [0.51, 1.10] |
| Left common carotid IMT | 0.66 [0.56, 0.76] |
| Framingham risk score | 3.00 [1.82, 4.25] |
| Fold TS | 207.94 [152.22, 286.03] |
AIDS, acquired immune deficiency syndrome; ART, antiretroviral therapy; BMI, body mass index; NNRTI, non-nucleoside reverse transcriptase inhibitor; SCA, subclinical atherosclerosis; IMT, intima–media thickness; TS, telomere shortening.